Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
>
2018
Pharma News, 2018
Teva Announces Top-Line Results from Phase III Studies of Subcutaneously Administered Reslizumab in Patients with Severe Eosinophilic Asthma
JERUSALEM--(BUSINESS WIRE)--Jan.
Eureka Therapeutics Closes $60 Million in Series D Financing to Advance Proprietary ARTEMIS™ T Cell Receptor Platform for Safer T Cell Therapies
EMERYVILLE, Calif.
Lupin intros generic Vibra-Tabs
Lupin has introduced its generic Vibra-Tabs (doxycycline hyclate).
Celgene Corporation to Acquire Juno Therapeutics, Inc., Advancing Global Leadership in Cellular Immunotherapy
SUMMIT, N.
Sanofi to Acquire Bioverativ for $11.6 Billion
Paris (France) and Waltham, Mass.
Regen BioPharma, Inc.'s Medicinal Chemistry Program has Identified Additional Compounds That Activate NR2F6
Regen BioPharma, Inc.
Oral Contraceptive Balcoltra Gets FDA Approval
Avion announced that the Food and Drug Administration (FDA) has approved Balcoltra (levonorgestrel and ethinyl estradiol tablets and ferrous bisglycinate tablets), a new oral contracep...
Amneal launches generic Entocort EC
Amneal Pharmaceuticals on Thursday introduced its generic Entocort EC (budesonide capsules).
Exelixis, Ipsen Report Positive Results on Lead Cancer Drug
Exelixis, Inc.
Statement from FDA Commissioner Scott Gottlieb, M.D., on new policy steps for strengthening public warning and notification of recalls
SILVER SPRING, Md.
This new blood test can detect early signs of 8 kinds of cancer
Scientists have developed a noninvasive blood test that can detect signs of eight types of cancer long before any symptoms of the disease arise.
Argentum Pharmaceuticals Wins Patent Invalidation Trial against the Sole Remaining Patent Protecting Janssen's ZYTIGA®
NEW YORK, Jan.
64
65
66
67
68
69
70
71
